For research use only. Not for therapeutic Use.
Melrilimab (GSK 3772847) is an IgG2-kappa anti-IL1RL1/ST2/IL33R/DER4/FIT-1 monoclonal antibody. Melrilimab can be used for the research of asthma[1].
| Catalog Number | I041577 |
| CAS Number | 2222865-46-3 |
| Purity | ≥95% |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 1, 2021 Recommended INN: List 85. |
